Preetam Shah, EVP, CFO & Treas at Brainstorm Cell Therapeutics, holds 335.96K shares in Cidara Therapeutics (Ticker: CDTX), holds 11.60K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).

See the Hottest Stocks Based on Insider Trading >

Preetam Shah
Brainstorm Cell Therapeutics (BCLI)
EVP, CFO & Treas

Ranked #73,911 out of 98,564 Corporate Insiders

Profitable Transactions

1 out of 3 Profitable Transactions

Average Return

-22.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.85%

CDTX

0.15%

BCLI

A breakdown of Preetam Shah's holdings

See the Top Stocks by Insiders

Insider Roles

Cidara Therapeutics
(CDTX)

CFO & CBO

Brainstorm Cell Therapeutics
(BCLI)

EVP, CFO & Treas

Roles that Preetam Shah holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Brainstorm Cell Therapeutics
(BCLI)

Rating:Informative Buy

Date:Dec 27, 2019 - Dec 27, 2020

Return:+23.90%

The most profitable trade made by Preetam Shah

See the Latest Stocks Traded by Insiders

Preetam Shah's Trading History

BCLI

Brainstorm Cell Therapeutics

Dec 31, 2020

EVP, CFO & Treas

Uninformative Sell

116.00K

$6.19K

CDTX

Cidara Therapeutics

Mar 20, 2024

CFO & CBO

Uninformative Buy

―

$4.24M

List of latest transactions for each holding click on a transaction to see Preetam Shah's performance on stock

See All Insider Trading from Today

Preetam Shah insider profile FAQ

What is the percentage of profitable transactions made by Preetam Shah?

The percentage of profitable transactions made by Preetam Shah is 33%.

What is the average return per transaction made by Preetam Shah?

The average return per transaction made by Preetam Shah is -22.10%.

What stocks does Preetam Shah hold?

Preetam Shah holds: BCLI, CDTX stocks.

What was Preetam Shah’s latest transaction?

Preetam Shah latest transaction was an Uninformative Buy of ―.

What was Preetam Shah's most profitable transaction?

Preetam Shah’s most profitable transaction was an Informative Buy of BCLI stock on December 27, 2019. The return on the trade was 23.90%.

What is Preetam Shah's role in Brainstorm Cell Therapeutics?

Preetam Shah's role in Brainstorm Cell Therapeutics is EVP, CFO & Treas.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Preetam Shah Insider Profile

Preetam Shah Brainstorm Cell Therapeutics (BCLI)EVP, CFO & Treas